美好医疗今年以来股价跌0.49%，近5个交易日跌8.19%，近20日跌7.19%，近60日涨23.27%。 今年以来美好医疗已经2次登上龙虎榜，最近一次登上龙虎榜为8月25日。 分红方面，美好医疗A股上市后累计派现2.48亿元。 10月15日，美好医疗盘中上涨2.04%，截至10:17，报22.99元/股，成交3644.94万元，换手率1.03%，总 市值130.78亿元。 机构持仓方面，截止2025年6月30日，美好医疗十大流通股东中，华宝中证医疗ETF（512170）位居第 二大流通股东，持股569.40万股，相比上期增加161.79万股。融通健康产业灵活配置混合A/B 资金流向方面，主力资金净流入7.50万元，特大单买入543.83万元，占比14.92%，卖出845.45万元，占 比23.20%；大单买入465.63万元，占比12.77%，卖出156.51万元，占比4.29%。 资料显示，深圳市美好创亿医疗科技股份有限公司位于广东省深圳市龙岗区宝龙街道宝龙六路3号新中 桥工业园B栋2楼，成立日期2010年7月15日，上市日期2022年10月12日，公司主营业务涉及医疗器械精 密组件及产品的设计开发、制造 ...

公司公告汇总 关于首次公开发行前已发行股份解除限售并上市流通的提示性公告 深圳市美好创亿医疗科技股份有限公司发布关于首次公开发行前已发行股份上市流通的提示性公告。本 次解除限售股东共5户，解除限售股份数量为412,300,000股，占公司总股本的72.4769%，限售期为自公 司首次公开发行股票并上市之日起36个月。本次解除限售股份的上市流通日期为2025年10月16日。截至 公告披露日，公司总股本为568,871,180股。本次申请解除股份限售的股东均严格履行了相关承诺，不存 在非经营性占用资金及违规担保情形。保荐机构对本次限售股份上市流通无异议。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 来自交易信息汇总：10月13日主力资金净流出1537.41万元，散户资金净流入1780.14万元。 来自公司公告汇总：美好医疗首次公开发行前已发行股份将于2025年10月16日解除限售并上市流 通，涉及股份412,300,000股，占公司总股本的72.4769%。 截至2025年10月13日收盘，美好医疗(301363)报收于23.28元 ...

证券日报网讯10月13日晚间，美好医疗（301363）发布关于首次公开发行前已发行股份上市流通的提示 性公告称，本次解除限售的股份为公司首次公开发行前已发行的股份。本次解除限售股东户数共计5 户，解除限售股份数量为412，300，000股，占公司总股本的72.4769%，限售期为自公司首次公开发行 股票并上市之日起36个月。本次解除限售股份的上市流通日期为2025年10月16日(星期四)。 ...

证券代码：301363 证券简称：美好医疗 公告编号：2025-067 深圳市美好创亿医疗科技股份有限公司 关于首次公开发行前已发行股份上市流通的提示性公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次解除限售的股份为深圳市美好创亿医疗科技股份有限公司（以下简 称"公司"、"发行人"）首次公开发行前已发行的股份。本次解除限售股东户数 共计5户，解除限售股份数量为412,300,000股，占公司总股本的72.4769%，限售 期为自公司首次公开发行股票并上市之日起36个月。 2、本次解除限售股份的上市流通日期为2025年10月16日（星期四）。 一、公司首次公开发行和股本变动情况 根据中国证券监督管理委员会《关于同意深圳市美好创亿医疗科技股份有限 公司首次公开发行股票注册的批复》（证监许可〔2022〕1441号）和深圳证券交 易所《关于深圳市美好创亿医疗科技股份有限公司人民币普通股股票在创业板上 市的通知》（深证上〔2022〕986号），公司首次向社会公众公开发行人民币普 通股（A股）4,427万股，并于2022年10月12日在深圳证券交 ...

关于深圳市美好创亿医疗科技股份有限公司 首次公开发行前已发行股份解除限售并上市流通 的核查意见 东兴证券股份有限公司（以下简称"东兴证券"或"保荐机构"）作为深圳 市美好创亿医疗科技股份有限公司（以下简称"美好医疗"、"上市公司"或"公 司"）首次公开发行股票并在创业板上市的保荐机构，根据《证券发行上市保荐 业务管理办法（2025 年修订）》《深圳证券交易所创业板股票上市规则（2025 年 修订）》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范 运作（2025 修订）》等相关法律、法规和规范性文件的规定，对美好医疗首次公 开发行前已发行股份解除限售并上市流通事项进行了核查，具体情况如下： 一、公司首次公开发行和股本变动情况 根据中国证券监督管理委员会《关于同意深圳市美好创亿医疗科技股份有限 公司首次公开发行股票注册的批复》（证监许可〔2022〕1441 号）和深圳证券交 易所《关于深圳市美好创亿医疗科技股份有限公司人民币普通股股票在创业板上 市的通知》（深证上〔2022〕986 号），公司首次向社会公众公开发行人民币普通 股（A 股）4,427 万股，并于 2022 年 10 月 12 ...

分红方面，美好医疗A股上市后累计派现2.48亿元。 机构持仓方面，截止2025年6月30日，美好医疗十大流通股东中，华宝中证医疗ETF（512170）位居第 二大流通股东，持股569.40万股，相比上期增加161.79万股。融通健康产业灵活配置混合A/B （000727）位居第三大流通股东，持股500.00万股，为新进股东。鹏华新兴产业混合（206009）位居第 四大流通股东，持股351.28万股，相比上期增加100.37万股。香港中央结算有限公司位居第六大流通股 东，持股299.86万股，相比上期增加28.48万股。圆信永丰聚优A（010469）位居第八大流通股东，持股 250.00万股，为新进股东。交银启道混合（010483）位居第九大流通股东，持股224.00万股，为新进股 东。交银成长动力一年混合A（011275）位居第十大流通股东，持股212.60万股，为新进股东。南方医 药创新股票A（010592）、大成价值增长混合A（090001）退出十大流通股东之列。 责任编辑：小浪快报 融资方面，美好医疗当日融资买入1530.91万元。当前融资余额1.94亿元，占流通市值的5.20%，融资余 额超过近一年9 ...

Investment Rating - The report maintains a "Recommended" investment rating for the pharmaceutical industry [1] Core Insights - The trend of Chinese innovative drugs going overseas is a long-term phenomenon, with external environmental changes having limited impact. In the first half of 2025, there were 72 License-out transactions, exceeding half of the total for 2024, with a total transaction amount 16% higher than in 2024. Notably, there were 16 transactions exceeding $1 billion each [2] - The small nucleic acid drug sector has seen significant breakthroughs, particularly in the treatment of chronic diseases such as hypertension and hyperlipidemia, with major collaborations and potential milestone payments indicating a robust commercial outlook [3] - The trend towards oral autoimmune drugs is gaining attention, with significant partnerships and clinical advancements in this area, highlighting the importance of oral formulations in autoimmune therapies [4] - Recent clinical data on long-acting insulin analogs shows promising weight loss results, with ongoing developments in combination therapies for metabolic diseases, indicating a growing market potential [5] - The CXO sector is gradually recovering, with an increase in License-out transactions serving as a vital funding source for biotech companies, leading to a resurgence in innovation and clinical development [6] - The 2025 national medical insurance negotiations and the commercial insurance innovative drug directory are crucial for companies involved, with a focus on orphan drugs and imported PD-1/L-1 products [7] Summary by Sections Industry Tracking - The pharmaceutical sector has underperformed compared to the CSI 300 index, with a recent weekly decline of 1.20% and a monthly decline of 3.38%, ranking 25th among 31 industry indices [22][26] Industry Trends and Valuation - The pharmaceutical industry index currently has a PE ratio of 39.05, above the five-year historical average of 31.36, indicating a higher valuation compared to historical trends [48][50] Recent Research Achievements - The research team has published several in-depth reports on various pharmaceutical topics, including the growth of the blood products industry and the potential of GLP-1 drugs in chronic disease management [53] Important Policies and News - Recent regulations have been introduced to standardize clinical research and ensure drug traceability, which will impact the pharmaceutical landscape significantly [55][56]

Economic Indicators - The National Bureau of Statistics will release the CPI and PPI data for September on October 15, with expectations of a year-on-year CPI growth rate remaining flat and a month-on-month increase of 0.2% [1] - The PPI is anticipated to show a year-on-year decline of 2.4% and a month-on-month decrease of 0.3% [1] Financial Data - Additional financial data for September, including new loans, M2, and social financing, is expected to be released next week [2] Oil Price Adjustment - The next round of fuel price adjustments will occur on October 13 at 24:00, with a projected decrease of 20 yuan per ton for gasoline and diesel based on a reference crude oil price of $64.97 per barrel, reflecting a change rate of -0.34% [3] Trade Events - The 138th Canton Fair will be held from October 15 to November 4, featuring a record exhibition area of 1.55 million square meters and over 32,000 participating companies [4] - The 2025 Bay Area Semiconductor Industry Ecosystem Expo will take place from October 15 to 17 in Shenzhen, attracting over 600 leading companies and institutions from more than 20 countries [4] - The 2025 World Intelligent Connected Vehicles Conference will be held in Beijing from October 16 to 18, focusing on innovations in AI, communication, data utilization, and chip technology within the automotive industry [4] Stock Market Developments - A total of 41 stocks will face lock-up expiration next week, with significant unlocks including 577 million shares of China Merchants Port valued at 11.967 billion yuan and 412 million shares of Meihua Medical valued at 9.804 billion yuan [5][6] - Notable stocks with high unlock ratios include Meihua Medical, Andar Intelligent, and Kecuan Technology, all exceeding 50% [5] New Stock Opportunities - Five new stocks are set to be issued next week, including Marco Polo on October 13, He Yuan Bio on October 14, Chao Ying Electronics on October 15, Xi'an Yicai on October 16, and Bi Bei Te on October 17 [9][10]

Economic Data Release - The National Bureau of Statistics will release the CPI and PPI data for September on October 15, with expectations of a year-on-year CPI growth rate remaining flat and a month-on-month increase of 0.2% [1] - The PPI is anticipated to show a year-on-year decline of 2.4% and a month-on-month decrease of 0.3% [1] - Additional financial data such as new loans, M2, and social financing for September may also be released next week [2] Oil Price Adjustment - The next round of fuel price adjustments will occur on October 13 at 24:00, based on the "ten working days" principle [3] - As of October 10, the average price of reference crude oil was $64.97 per barrel, indicating a change rate of -0.34%, which suggests a potential decrease of 20 yuan per ton in domestic gasoline and diesel prices [3] Trade Fair and Conferences - The 138th Canton Fair will be held from October 15 to November 4 in Guangzhou, featuring a record exhibition area of 1.55 million square meters and over 32,000 participating companies [4] - The 2025 Bay Area Semiconductor Industry Ecosystem Expo will take place from October 15 to 17 in Shenzhen, attracting over 600 leading enterprises and institutions from more than 20 countries [4] - The 2025 World Intelligent Connected Vehicle Conference will be held in Beijing from October 16 to 18, focusing on innovations in AI, communication, data utilization, and chip technology within the automotive industry [4] Stock Unlocking Events - A total of 41 stocks will face unlocking next week, with significant unlocks including 577 million shares of China Merchants Port, valued at 11.967 billion yuan, and 412 million shares of Meihua Medical, valued at 9.804 billion yuan [5][6] - The unlocking ratios for several companies exceed 50%, including Meihua Medical, Andar Intelligent, and Kecuan Technology [5] New Stock Opportunities - Five new stocks are set to be issued next week, including Marco Polo on October 13, He Yuan Biological on October 14, Chaoying Electronics on October 15, Xi'an Yicai on October 16, and Bibet on October 17 [9][10]

Core Viewpoint - A total of 40 companies will have their restricted shares unlocked next week, amounting to 3.323 billion shares with a total market value of 79.774 billion yuan based on the closing price on October 10 [1] Group 1: Unlocking Schedule and Market Impact - The peak unlocking day is October 13, with 20 companies unlocking shares worth a total of 55.417 billion yuan, accounting for 69.46% of the total unlocking scale for the week [1] - The companies with the highest unlocking market value on October 10 are: China Merchants Port (11.967 billion yuan), Meihua Medical (9.804 billion yuan), and Weijie Chuangxin (8.207 billion yuan) [1] Group 2: Individual Company Unlocking Details - The companies with the largest number of unlocked shares are: China Merchants Port (577 million shares), Qingnong Commercial Bank (500 million shares), and Meihua Medical (412 million shares) [1] Group 3: Types of Restricted Shares - The types of unlocked shares include: 14 companies with original shareholders' restricted shares, 8 companies with restricted shares from directed placements, 6 companies with restricted shares from equity incentives, 5 companies with general equity incentive shares, 4 companies with original placement shares, 2 companies with original shareholders' strategic placement shares, and 1 company with strategic placement shares [1]